Key Takeaways
- • Enzo Health closed a $20M Series A funding round led by N47, with participation from existing investors Gradient, Tandem Ventures, and Rigby Watts, bringing total funding to $26M since launch in 2024.
- • The AI-driven home health platform has achieved 40X revenue growth in twelve months and now serves organizations supporting over 500,000 patients annually, demonstrating rapid market traction in post-acute care.
- • Enzo's integrated software automates the entire home health workflow—from referral through reimbursement—addressing fragmentation in legacy systems and regulatory compliance gaps that have historically squeezed agency margins.
- • The company is positioned to capitalize on structural demographic tailwinds, with more than 10,000 Americans turning 65 daily, driving unprecedented demand for in-home and post-acute care delivery.
- • Series A funding will fuel expansion into skilled nursing and hospice care segments, extending the platform's addressable market beyond current home health verticals.
Summary
Enzo Health announced a $20M Series A funding round on May 4, 2026, led by growth-stage investor N47, with support from existing backers Gradient, Tandem Ventures, and Rigby Watts. The round brings the company's total raised capital to $26M since its launch in 2024, positioning the AI-driven platform to accelerate expansion in a market experiencing structural growth driven by aging demographics.
Founded in 2024, Enzo Health has demonstrated exceptional early-stage momentum. The company has achieved 40X revenue growth over the past twelve months and is now embedded within healthcare organizations that collectively serve over 500,000 patients annually. This rapid scaling reflects both strong product-market fit and the acute operational pain points facing home health agencies nationwide.
The company's core offering is a unified, AI-driven software platform that consolidates fragmented home health operations into a single system. Enzo's solution automates front-office functions (referral intake), clinical operations (care coordination), and back-office processes (billing and reimbursement), eliminating the need for agencies to stitch together multiple disconnected point solutions. This integration is operationally significant; it reduces administrative overhead, minimizes regulatory compliance risk, and allows care providers to redirect resources toward clinical delivery rather than system management. According to the company, the platform bolsters provider margins while returning "precious hours to nurses and clinicians."
The capital raise directly addresses a structural opportunity in post-acute care. The United States is experiencing a demographic inflection, with more than 10,000 Americans turning 65 each day. This cohort shift is accelerating demand for in-home care delivery—a setting increasingly preferred by patients and payers alike due to cost efficiency and quality-of-life considerations. However, the home health provider ecosystem remains operationally constrained, with legacy software creating inefficiencies and cost pressures. Enzo's platform targets this gap.
The $20M Series A will fund expansion into adjacent post-acute care segments, specifically skilled nursing facilities and hospice care. This vertical expansion broadens the addressable market and deepens the company's position within the broader continuum of care ecosystem, positioning it as a broader post-acute care operating system rather than a single-vertical point solution.
Founded in 2024, Enzo Health has demonstrated exceptional early-stage momentum. The company has achieved 40X revenue growth over the past twelve months and is now embedded within healthcare organizations that collectively serve over 500,000 patients annually. This rapid scaling reflects both strong product-market fit and the acute operational pain points facing home health agencies nationwide.
The company's core offering is a unified, AI-driven software platform that consolidates fragmented home health operations into a single system. Enzo's solution automates front-office functions (referral intake), clinical operations (care coordination), and back-office processes (billing and reimbursement), eliminating the need for agencies to stitch together multiple disconnected point solutions. This integration is operationally significant; it reduces administrative overhead, minimizes regulatory compliance risk, and allows care providers to redirect resources toward clinical delivery rather than system management. According to the company, the platform bolsters provider margins while returning "precious hours to nurses and clinicians."
The capital raise directly addresses a structural opportunity in post-acute care. The United States is experiencing a demographic inflection, with more than 10,000 Americans turning 65 each day. This cohort shift is accelerating demand for in-home care delivery—a setting increasingly preferred by patients and payers alike due to cost efficiency and quality-of-life considerations. However, the home health provider ecosystem remains operationally constrained, with legacy software creating inefficiencies and cost pressures. Enzo's platform targets this gap.
The $20M Series A will fund expansion into adjacent post-acute care segments, specifically skilled nursing facilities and hospice care. This vertical expansion broadens the addressable market and deepens the company's position within the broader continuum of care ecosystem, positioning it as a broader post-acute care operating system rather than a single-vertical point solution.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.